BioOra
PrivateLast Round
Grant
Jun 19, 2026
Est. Valuation
$112.52M
Total Funding Raised
$26.74M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
BioOra is a biotechnology company that develops and manufactures third-generation CAR T-cell therapies for cancer treatment.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioOra Comparables
Compare BioOra with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Wellington Zhaotai Therapies Limited | 78% | |
| Galapagos NV | 74% | |
| Resilience | 68% |
BioOra Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 19, 2026 | ||||
| Series A Extension | Jun 4, 2026 | ||||
| Series A | Oct 2, 2025 | ||||
| Series A Extension | Sep 1, 2025 | ||||
| VC Round | Apr 1, 2025 | ||||
Early Funding | Nov 22, 2024 |
BioOra Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Callaghan Innovation | Seed |
| Bridgewest Ventures | Series A, Early Funding, Seed, VC Round |
| Queensland Government | Grant |
| Mainland Angel Investors | Early Funding, VC Round, Series A Extension |
| Cure Kids Ventures | Early Funding |
| Angel Investors Marlborough | Early Funding |
| Booster Innovation Fund | Early Funding, Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 25, 2026
Grew 20% QoQ, from 51 to 61 employees.
- Sep 2, 2026
Grew 16% QoQ, from 50 to 58 employees.
Recent news
Latest coverage and updates
- receives_financingAug 5, 2026
BioOra Limited received financing of $15M on Jul 1st '25.
BioOra Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about BioOra's valuation, stock price, and market status.
Is BioOra a public or private company?
BioOra is a private company.
What is the current stock price of BioOra?
BioOra is a private company, so its shares have no public market price. Caplight tracks BioOra's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BioOra worth (valuation)?
BioOra's valuation is estimated at $112.5M based on funding round data.
Can I buy BioOra stock?
BioOra shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BioOra's last funding round?
BioOra's most recent funding round was Grant on June 19, 2026.
Who are the main investors in BioOra?
Key investors in BioOra include Bridgewest Ventures, Mainland Angel Investors.
Will BioOra IPO soon?
No public IPO plans have been announced for BioOra.
How can I track BioOra secondary market activity?
Caplight tracks bids, offers, and trades in BioOra's shares on secondary markets.